프리필드 시린지 시장 : 재료별, 약물 유형별, 디자인별, 제품 유형별, 사용성별, 제조 방법별, 최종 사용자별, 지역별 시장 규모, 점유율, 전망 및 기회 분석(2023-2030년)

Prefilled Syringes Market, by Material, by Drug Type, by Design, by Product Type, by Usability, by Manufacturing Method, by End User, by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

US $ 4,500 ￦ 6,267,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,749,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,928,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

프리필드 시린지는 주사할 약물이 미리 채워진 1회용 주사기입니다. 이 주사기에는 제조업체가 주사바늘을 장착한 주사기입니다. 이 주사기는 미리 채워져 있기 때문에 간호사나 환자가 약물을 준비하고 바늘에 넣을 필요가 없으며, 대신 적절한 용량이 이미 배럴에 존재하여 신속하게 주사할 준비가 되어 있습니다. 또한 미리 채워진 주사기는 정확도가 높기 때문에 더 안전하게 사용할 수 있습니다. 일부 프리필드 시린지의 카트리지는 자가흡입식 주사기에 맞게 제작되어 플런저를 누르지 않고도 피부를 관통하여 약물을 공급할 수 있습니다. 이렇게하면 복용량이 원활하게 공급되고 주사가 적절한 깊이에 도달 할 수 있습니다.

시장 역학

프리필드 시린지 수요를 주도하는 만성 질환의 발생률 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2022년 7월에 업데이트된 미국 질병예방통제센터(CDC)의 만성질환 관련 데이터에 따르면, 미국 성인 10명 중 6명이 만성질환을 앓고 있으며, 10명 중 4명 이상이 2개 이상의 만성질환을 앓고 있는 것으로 나타났습니다. 암은 세계 사람들이 앓고 있는 가장 흔한 만성질환입니다. 예를 들어, GLOBOCAN 2020 보고서에 따르면, 2020년 암에 걸린 세계 인구는 약 1,929만 2,789명이었습니다. 이 숫자는 2040년에는 28,887,940명까지 증가할 것으로 추정됩니다. 일부 유형의 암은 새로운 약물과 생물학적 제제의 도움으로 치료되고 있으며, 이는 예측 기간(2023-2030년) 동안 프리필드 시린지에 대한 수요를 증가시킬 것으로 예상됩니다. 따라서 세계적으로 암 발병률이 증가하고 있으며, 이는 예측 기간 동안 미리 채워진 주사기 시장의 성장을 가속할 것으로 예상됩니다.

제품 포트폴리오를 확장하기 위해 시장 참여자들의 다양한 규제 기관의 승인이 증가함에 따라 예측 기간 동안 시장 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2022년 12월 다국적 제약 기업인 Alembic Pharmaceuticals Limited는 미국 식품의 약국으로부터 약식 신약 신청 (ANDA), 단일 용량 프리필드시린지당 250mg/ 5mL (50mg/mL)의 Fulvestrant 주사에 대한 최종 승인을 받았다고 발표했습니다. Fulvestrant 주사는 유방암 치료에 사용되는 에스트로겐 수용체 길항제입니다.

본 조사의 주요 특징

• 이 보고서는 세계 프리필드 시린지 시장을 상세하게 분석했으며, 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR) 정보를 제공합니다.
• 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안의 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 중요한 고려 사항도 제공합니다.
• 세계 프리필드 시린지 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과 및 전략과 같은 매개 변수를 기반으로 프로파일을 작성합니다.
• 조사 대상 주요 기업으로는 Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, Stevanato Group S.p.A. 등이 있습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 프리필드 시린지 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 프리필드 시린지 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 상황 개요

• 보고서 개요
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장의 매력 분석
  • 시장 기회
• 제품 론치
• 인수합병(M&A) 및 협업
• 규제 가이드라인과 준수
• 주요 발전
• PEST 분석
• 기술 상황
• 서비스 비용 분석

제4장 세계의 프리필드 시린지 시장 - COVID-19의 영향 분석

• 경제적 영향
• COVID-19 역학
• 수요 및 공급에 대한 영향

제5장 세계의 프리필드 시린지 시장 : 재료별, 2018-2030년

• 유리
• 플라스틱/폴리머

제6장 세계의 프리필드 시린지 시장 : 약제 유형별, 2018-2030년

• 생물제제
• 단클론항체
• 혈액제재
• 기타(에리스로포이에틴, 치료용 단백질 등)
• 백신
• 결합 백신
• 생백신
• 재조합 백신
• 기타(바이러스 유사 입자(VLP),바이러스 벡터 백신)
• 인슐린 제제
• 항응고제
• 생리 식염수 시린지 세정
• 기타

제7장 세계의 프리필드 시린지 시장 : 디자인별, 2018년-2030년

• 싱글 챔버
• 듀얼 챔버
• 멀티 챔버

제8장 세계의 프리필드 시린지 시장 : 제품 유형별, 2018년-2030년

• Staked in-needle pre-filled syringes
• Needle-free pre-filled syringes

제9장 세계의 프리필드 시린지 시장 : 사용성별, 2018년-2030년

• 일회용
• 재이용 가능

제10장 세계의 프리필드 시린지 시장 : 제조 방법별, 2018년-2030년

• Captive
• Merchant

제11장 세계의 프리필드 시린지 시장 : 최종사용자별, 2018년-2030년

• 병원
• 진료소
• 외래수술센터(ASC)
• 기타

제12장 세계의 프리필드 시린지 시장 : 지역별, 2018년-2030년

• 북미
• 미국
• 캐나다
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카

제13장 경쟁 구도

• Gerresheimer AG
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• Terumo Corporation
• Nipro Europe Group Companies
• B.Braun SE
• GSK plc.
• Pfizer Inc.
• Bayer AG
• Polymedicure
• Amsino International, Inc.
• Leeford Healthcare Limited
• Regeneron Pharmaceuticals Inc.
• Ypsomed AG
• SOL-Millennium
• Stevanato Group S.p.A.

제14장 섹션

• 조사 방법
• 출판사에 대해

LSH

영문 목차

영문목차

Pre-filled syringes are single-use syringes that are pre-loaded with the medication that will be injected. It is a single dose of medicine with a needle attached by the manufacturer. As these syringes are prefilled, nurses or patients do not need to prepare the medication and pull it into the needle; instead, the appropriate dosage is already present in the barrel and is ready for speedy injection. Moreover, prefilled syringes are safer to use since they are highly accurate. Some cartridges of prefilled syringes are made to fit into self-aspirating syringes, which penetrate the skin and provide drugs without the need to press a plunger. This guarantees that doses are supplied smoothly and that injections reach the proper depth.

Market Dynamics

Increasing incidence of chronic diseases which leads to driving the demand of prefilled syringes as its treatment is expected to fuel the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention data on chronic diseases updated in July 2022, around six in ten adults in the U.S. were affected by a type of chronic disease, and over four in ten adults were affected by two or more chronic diseases. Cancer is the most common chronic disease affecting people worldwide. For instance, according to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounted for around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. Several types of cancer are treated with the help of novel drugs and biologics, which is expected to increase the demand for prefilled syringes over forecast period (2023-2030). Thus, the rising cancer cases across the world is expected to boost the growth of the prefilled syringes market over the forecast period.

The increasing approvals from various regulatory agencies by market players to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2022, Alembic Pharmaceuticals Limited, a multinational pharmaceutical company, announced that it had received final approval from the U.S. Food & Drug Administration for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

Key features of the study:

• This report provides in-depth analysis of the global prefilled syringes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global prefilled syringes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Gerresheimer AG, Becton Dickinson and Company, West Pharmaceutical Services, Inc., Terumo Corporation, Nipro Europe Group Companies, B. Braun SE, Sanofi, GSK plc., Pfizer Inc., Bayer AG, Polymedicure, Amsino International, Inc., Leeford Healthcare Limited, Torrent Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Ypsomed AG, SOL-Millennium, and Stevanato Group S.p.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prefilled syringes market

Detailed Segmentation:

• Global Prefilled Syringes Market, By Material:
  • Glass
  • Plastic/Polymer
• Global Prefilled Syringes Market, By Drug Type:
  • Biologics
    • Monoclonal Antibodies
    • Blood Products
    • Others (Erythropoietin, Therapeutic proteins, among others)
  • Vaccines
    • Conjugated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Others (Virus-like particles (VLPs), Viral vector vaccines)
  • Insulin
  • Anticoagulants
  • Flush Saline Syringes
  • Others
• Global Prefilled Syringes Market, By Design:
  • Single-chamber
  • Dual-chamber
  • Multi-chambered
• Global Prefilled Syringes Market, By Product Type:
  • Staked in-needle pre-filled syringes
  • Needle-free pre-filled syringes
• Global Prefilled Syringes Market, By Usability:
  • Disposable
  • Reusable
• Global Prefilled Syringes Market, By Manufacturing Method:
  • Captive
  • Merchant
• Global Prefilled Syringes Market, By End User:
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• Global Prefilled Syringes Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Gerresheimer AG
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Nipro Europe Group Companies
  • B. Braun SE
  • Sanofi
  • GSK plc.
  • Pfizer Inc.
  • Bayer AG
  • Polymedicure
  • Amsino International, Inc.
  • Leeford Healthcare Limited
  • Torrent Pharmaceuticals Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Ypsomed AG
  • SOL-Millennium
  • Stevanato Group S.p.A.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Material
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Design
  • Market Snapshot, By Product Type
  • Market Snapshot, By Usability
  • Market Snapshot, By Manufacturing Method
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• Service Cost Analysis

4. Global Prefilled Syringes Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Prefilled Syringes Market, By Material, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Glass
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Plastic/Polymer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Prefilled Syringes Market, By Drug Type, 2018-2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Monoclonal Antibodies
• Blood Products
• Others (Erythropoietin, Therapeutic proteins, among others)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Conjugated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Others (Virus-like particles (VLPs), Viral vector vaccines)
• Insulin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Anticoagulants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Flush Saline Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Prefilled Syringes Market, By Design, 2018 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Single-chamber
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Dual-chamber
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Multi-chambered
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Prefilled Syringes Market, By Product Type, 2018 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Staked in-needle pre-filled syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Needle-free pre-filled syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Global Prefilled Syringes Market, By Usability, 2018 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Disposable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Reusable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

10. Global Prefilled Syringes Market, By Manufacturing Method, 2018 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Captive
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Merchant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

11. Global Prefilled Syringes Market, By End User, 2018 - 2030, (US$ Billion

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segments Trends
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

12. Global Prefilled Syringes Market, By Region, 2018 - 2030, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Design, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Usability, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Manufacturing Method, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Billion)
• GCC
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

13. Competitive Landscape

• Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• Terumo Corporation
• Nipro Europe Group Companies
• B.Braun SE
• GSK plc.
• Pfizer Inc.
• Bayer AG
• Polymedicure
• Amsino International, Inc.
• Leeford Healthcare Limited
• Company Highlights
• Regeneron Pharmaceuticals Inc.
• Ypsomed AG
• SOL-Millennium
• Stevanato Group S.p.A.

14. Section

• Research Methodology
• About Us

관련자료